R. Janet Whitmore - Feb 9, 2024 Form 4 Insider Report for NANOPHASE TECHNOLOGIES Corp (NANX)

Role
Director
Signature
By Jess Jankowski under UPA for R. Janet Whitmore
Stock symbol
NANX
Transactions as of
Feb 9, 2024
Transactions value $
$72,973
Form type
4
Date filed
2/13/2024, 04:00 PM
Previous filing
Dec 29, 2023
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NANX Common Stock Purchase $73K +182K +11.09% $0.40* 1.83M Feb 9, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NANX Deferred Common Stock 20K Feb 9, 2024 Common Stock 20K Direct F2, F3, F4
holding NANX Common Stock (right to purchase) 2K Feb 9, 2024 Common Stock 2K $0.90 Direct F5
holding NANX Common Stock (right to purchase) 2K Feb 9, 2024 Common Stock 2K $1.05 Direct F5
holding NANX Common Stock (right to purchase) 2K Feb 9, 2024 Common Stock 2K $1.18 Direct F5
holding NANX Common Stock (right to purchase) 2K Feb 9, 2024 Common Stock 2K $0.84 Direct F5
holding NANX Common Stock (right to purchase) 2K Feb 9, 2024 Common Stock 2K $1.85 Direct F5
holding NANX Common Stock (right to purchase) 2K Feb 9, 2024 Common Stock 2K $1.10 Direct F5
holding NANX Common Stock (right to purchase) 2K Feb 9, 2024 Common Stock 2K $0.99 Direct F5
holding NANX Common Stock (right to purchase) 10K Feb 9, 2024 Common Stock 10K $0.68 Direct F6
holding NANX Common Stock (right to purchase) 10K Feb 9, 2024 Common Stock 10K $0.82 Direct F7
holding NANX Common Stock (right to purchase) 6.67K Feb 9, 2024 Common Stock 6.67K $0.45 Direct F7
holding NANX Common Stock (right to purchase) 20K Feb 9, 2024 Common Stock 20K $4.17 Direct F6
holding NANX Common Stock (right to purchase) 20K Feb 9, 2024 Common Stock 20K $1.17 Direct F6
holding NANX Common Stock (right to purchase) 12.6K Feb 9, 2024 Common Stock 12.6K $0.61 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased as part of the Company's recent shareholder rights offering.
F2 Each share of deferred common stock represents a right to receive one share of common stock.
F3 The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F4 Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
F5 The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.
F6 Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.
F7 Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.